These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32949419)

  • 21. Do Smokers' Perceptions of the Harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an Aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys.
    Yong HH; Gravely S; Borland R; Gartner C; Michael Cummings K; East K; Tagliaferri S; Elton-Marshall T; Hyland A; Bansal-Travers M; Fong GT
    Nicotine Tob Res; 2022 Aug; 24(9):1413-1421. PubMed ID: 35368082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of nicotine vaping products used by participants in the 2016 ITC Four Country Smoking and Vaping Survey.
    O'Connor RJ; Fix BV; McNeill A; Goniewicz ML; Bansal-Travers M; Heckman BW; Cummings KM; Hitchman S; Borland R; Hammond D; Levy D; Gravely S; Fong GT
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):15-23. PubMed ID: 30701622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and changes over time of nicotine vaping products used by vapers in the 2016 and 2018 ITC Four Country Smoking and Vaping Surveys.
    Felicione NJ; Fix BV; McNeill A; Cummings KM; Goniewicz ML; Hammond D; Borland R; Heckman BW; Bansal-Travers M; Gravely S; Hitchman SC; Levy DT; Fong GT; O'Connor R
    Tob Control; 2022 Aug; 31(e1):e66-e73. PubMed ID: 33753550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine vaping product use, harm perception and policy support among pharmacy customers in Brisbane, Australia.
    Erku DA; Gartner CE; Tengphakwaen U; Morphett K; Steadman KJ
    Drug Alcohol Rev; 2019 Sep; 38(6):703-711. PubMed ID: 31486151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exposure to and perceptions of health warning labels on nicotine vaping products: findings from the 2016 International Tobacco Control Four Country Smoking and Vaping Survey.
    McDermott MS; Li G; McNeill A; Hammond D; Thrasher JF; O'Connor RJ; Cummings KM; Borland R; Fong GT; Hitchman SC
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):134-143. PubMed ID: 30618081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the content and source credibility of health and risk messages related to nicotine vaping products have an impact on harm perception and behavioural intentions? A systematic review.
    Erku DA; Bauld L; Dawkins L; Gartner CE; Steadman KJ; Noar SM; Shrestha S; Morphett K
    Addiction; 2021 Dec; 116(12):3290-3303. PubMed ID: 33751707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Don't Know" Responses for Nicotine Vaping Product Features among Adult Vapers: Findings from the 2018 and 2020 ITC Four Country Smoking and Vaping Surveys.
    Felicione NJ; Cummings KM; Gravely S; Hammond D; McNeill A; Borland R; Fong GT; O'Connor RJ
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How Does the Use of Flavored Nicotine Vaping Products Relate to Progression Toward Quitting Smoking? Findings From the 2016 and 2018 ITC 4CV Surveys.
    Li L; Borland R; Cummings KM; Fong GT; Gravely S; Smith DM; Goniewicz ML; O'Connor RJ; Thompson ME; McNeill A
    Nicotine Tob Res; 2021 Aug; 23(9):1490-1497. PubMed ID: 33631007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the implementation of a prescription only regulatory model for nicotine vaping products: A qualitative study on the experiences and views of healthcare professionals.
    Morphett K; Holland A; Ward S; Steadman KJ; Zwar NA; Gartner C
    Int J Drug Policy; 2024 Mar; 125():104353. PubMed ID: 38364356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of Non-Cigarette Tobacco and Nicotine Use Among Current Cigarette Smokers and Recent Quitters: Findings From the 2020 ITC Four Country Smoking and Vaping Survey.
    Li L; Borland R; Cummings KM; Gravely S; Quah ACK; Fong GT; Miller CR; Goniewicz ML; Le Grande M; McNeill A
    Nicotine Tob Res; 2021 Aug; 23(9):1611-1616. PubMed ID: 33693833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prices, use restrictions and electronic cigarette use-evidence from wave 1 (2016) US data of the ITC Four Country Smoking and Vaping Survey.
    Cheng KW; Chaloupka FJ; Shang C; Ngo A; Fong GT; Borland R; Heckman BW; Levy DT; Cummings KM
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):115-122. PubMed ID: 30690802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examining acute psychopharmacological effects of nicotine vaping versus heated tobacco products in a randomised crossover study of product naïve adult smokers.
    Kale D; Tattan-Birch H; Brown J; Cox S; Dawkins L; Goniewicz ML; Morris K; Shahab L
    Sci Rep; 2023 Dec; 13(1):22676. PubMed ID: 38114686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do Current Smokers and Ex-Smokers Who Use Nicotine Vaping Products Daily Versus Weekly Differ on Their Reasons for Vaping? Findings from the 2020 ITC Four Country Smoking and Vaping Survey.
    Gravely S; Yong HH; Reid JL; East KA; Gartner CE; Levy DT; Cummings KM; Borland R; Quah ACK; Bansal-Travers M; Ouimet J; Fong GT
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36361015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reasons for regular vaping and for its discontinuation among smokers and recent ex-smokers: findings from the 2016 ITC Four Country Smoking and Vaping Survey.
    Yong HH; Borland R; Cummings KM; Gravely S; Thrasher JF; McNeill A; Hitchman S; Greenhalgh E; Thompson ME; Fong GT
    Addiction; 2019 Oct; 114 Suppl 1(Suppl 1):35-48. PubMed ID: 30821861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in cigarette smoking quit attempts and cessation between adults who did and did not take up nicotine vaping: Findings from the ITC four country smoking and vaping surveys.
    Gravely S; Meng G; Hammond D; Hyland A; Michael Cummings K; Borland R; Kasza KA; Yong HH; Thompson ME; Quah ACK; Ouimet J; Martin N; O'Connor RJ; East KA; McNeill A; Boudreau C; Levy DT; Sweanor DT; Fong GT
    Addict Behav; 2022 Sep; 132():107339. PubMed ID: 35605409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotine vaping products as a harm reduction tool among smokers: Review of evidence and implications for pharmacy practice.
    Erku D; Gartner CE; Morphett K; Snoswell CL; Steadman KJ
    Res Social Adm Pharm; 2020 Sep; 16(9):1272-1278. PubMed ID: 32061550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Decision-Theoretic Public Health Framework for Heated Tobacco and Nicotine Vaping Products.
    Levy DT; Cadham CJ; Li Y; Yuan Z; Liber AC; Oh H; Travis N; Issabakhsh M; Sweanor DT; Sánchez-Romero LM; Meza R; Cummings KM
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of nicotine vaping products for tobacco control in ASEAN low-income and middle-income countries: in-depth interviews with experts from the region.
    Stubbs T; White V; Yong HH; Toumbourou JW
    BMJ Open; 2023 Sep; 13(9):e073106. PubMed ID: 37730408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential effects of tobacco control in China: projections from the China SimSmoke simulation model.
    Levy D; Rodríguez-Buño RL; Hu TW; Moran AE
    BMJ; 2014 Feb; 348():g1134. PubMed ID: 24550245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential deaths averted in USA by replacing cigarettes with e-cigarettes.
    Levy DT; Borland R; Lindblom EN; Goniewicz ML; Meza R; Holford TR; Yuan Z; Luo Y; O'Connor RJ; Niaura R; Abrams DB
    Tob Control; 2018 Jan; 27(1):18-25. PubMed ID: 28970328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.